Weight in Medical Technology

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

Improvements in Systolic Blood Pressure and Triglycerides Also Observed NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ), and Alkermes, Inc. (Nasdaq: ALKS ) today announced long-term, interim results from the ...

Studies Show AFRESA(R) Controls Post-Meal Sugar Levels With Less Weight Gain and Hypoglycemia Risk for Diabetes Patients

Latest data on ultra rapid acting insulin presented at the American Diabetes Association's 69th Scientific Sessions NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA(R) (insulin human [rDNA or...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

- Late-Breaking Data from Pivotal BLOOM Trial Presented at the American Diabetes Association's 69th Scientific Sessions Expand on Previously Announced Positive Top-Line Results - NEW ORLEANS, June 6, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today...

New Weight Loss Hope for People with Diabetes

In Clinical Test, NutriSystem D Leads to Weight Loss, Lower Blood Sugar and Improved A1C HORSHAM, Pa., April 21 /PRNewswire-FirstCall/ -- NutriSystem (Nasdaq: NTRI ), a leading weight loss program that delivers to your door, today announced the launch of new NutriSystem D, a weight loss pro...

Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study

SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass., March 31 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) today announced positive results from DURATION-2, the second in a series of studies designed to...

Gaining Too Much Weight During Pregnancy Nearly Doubles Risk of Having a Heavy Baby

Heavy babies have more birth complications; they are also more likely to become overweight or obese children and adults PORTLAND, Ore., Oct. 31 /PRNewswire/ -- A study by the Kaiser Permanente Center for Health Research of more than 40,000 women and their babies found that women who gained m...

Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success

WALTHAM, Mass. and DANVILLE, Pa., Sept. 18 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ), and Geisinger Health System, today announced a research collaboration to explore the role of genetics in obesity. The goal of the collaboration is to develop a series of genetic tests...

Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss

CORAL GABLES, Fla., Aug 21 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today reported that animal data from a new study sponsored by scientists at the U.S. Department of Energy's Brookhaven National Laboratory appears to demonstrate that taking vigabatrin ...

A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share in the Obesity Drug Market

Advantages in Efficacy and Delivery Will Make Qnexa the New Clinical Gold Standard Drug by 2011, According to a New Report from Decision Resources WALTHAM, Mass., June 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and ...

Women Who Gain Excessive Weight During Pregnancy More Likely to Have Overweight Children

PHILADELPHIA, June 9 /PRNewswire-USNewswire/ -- Children of mothers who gain more than the recommended amount of weight during pregnancy are more likely to be overweight at age seven, say researchers from The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medi...

Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss

Submitted to FDA for Stand-Alone Therapy in Q1 2008 SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY ) today announced additional results from a study of patients with type 2 diabetes who were unable t...

Study Finds Personal and Web-Based Support Equal Weight Loss Success

Kaiser Permanente Helps Members Achieve Weight Loss with Education & Outreach OAKLAND, Calif., March 11 /PRNewswire/ -- Findings in the Journal of the American Medical Association on the largest weight loss maintenance study to date reinforce Kaiser Permanente'...

Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study

'The Diabetes Educator' published study showing Medifast's effectiveness in patients with type 2 diabetes OWINGS MILLS, Md., Feb. 11 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED ) today announced that a study conducted by researchers at the Johns Hopkins University Bl...

Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss

PHILADELPHIA, Feb. 1 /PRNewswire-USNewswire/ -- Obese teenagers who succeeded in losing weight in a year-long medically supervised weight control program also saw their bone mineral content increase over that period, say researchers from The Children's Hospital of Philadelphia. The finding was...

Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)

-Patients treated with Lovenox(R) (enoxaparin sodium injection) were also less likely to be readmitted to hospital within 90 days- BRIDGEWATER, N.J., Dec 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today the results of a study that demonstrated total hospital direct medical cos...

Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels

BOULDER, Colo., Oct. 22 /PRNewswire/ -- Sciona, Inc., a leader in the science of nutrigenetics, today announced the results of a pivotal study published by Nutrition Journal, which demonstrates substantial advances in long term weight management and blood glucose levels as a result of personal...

Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects

NEW ORLEANS and PITTSBURGH, Oct. 22 /PRNewswire-FirstCall/ -- Data presented at the 2007 Annual Scientific Meeting of NAASO, The Obesity Society, found that patient satisfaction with alli(R) (orlistat 60mg), the only FDA- approved, over-the-counter (OTC) weight loss product, was connected to t...

Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health

NEW ORLEANS, Oct. 8 /PRNewswire-USNewswire/ -- As the number of overweight children in the United States approaches epidemic proportions, one group of surgeons is taking an active role in researching new ways to reduce obesity rates in children. Evan Nadler, MD, and colleagues at the New York ...

DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study

SOMERSET, N.J., Sept. 25 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. ("DOV", or the "Company") (OTCBB and Pink Sheets: DOVP) announced today additional Phase Ib results for DOV 21,947, its lead triple reuptake inhibitor ("TRIP") for the treatment of depression and obesity. A preliminary...

ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx

WINDSOR, Ontario, Sept. 19 /PRNewswire/ -- ArtJen Complexus Holdings Corp. (http://www.fbcx.com ) today announced that, following the results of their clinical trial with obese type 2 diabetics and an animal study at the National Institutes of Health, FBCx is being studied by a major US west-...

The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management

WESTBURY, N.Y., Aug. 25 /PRNewswire/ -- "Weight management is serious business. National health authorities are concerned that more than half of Americans are over weight, and for many obesity is not merely a matter of looking unattractive. It is a health hazard. Then why leave it to amateurs ...

Diabetes Gene Raises Odds of Lower Birth Weight

PHILADELPHIA, July 29 /PRNewswire-USNewswire/ -- Pediatric researchers have found that a gene previously shown to be involved in the development of type 2 diabetes also predisposes children to having a lower birth weight. The finding sheds light on a possible genetic influence on ...

FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight

ROCKVILLE, Md. , June 8 /PRNewswire-FirstCall/ -- Attached is a press release issued yesterday by GlaxoSmithKline (GSK), regarding new Phase 2 data for Syncria(R) (albiglutide) presented at the American Diabetes Association 69th Scientific Sessions in New Orleans. (Logo: http://www.newsco...

Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight

LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria(R) (albiglutide) significantly redu...

Concord Grape Juice Has No Significant Impact on Body Weight

Recent study revealed that drinking polyphenol-rich 100% Concord grape juice was not associated with changes in appetite, energy intake or body weight CONCORD, Mass., Oct. 6 /PRNewswire/ -- Regular consumption of 100% polyphenol-rich Concord grape juice did not cause significant weight gain,...

Behavioral Modification Programs Help Obese Children Manage Their Weight

ROCKVILLE, Md., Sept. 29 /PRNewswire-USNewswire/ -- Obese school-age kids and teens can lose weight or prevent further weight gain if they participate in medium- to high-intensity behavioral management programs, according to a new report released today by HHS' Agency for Healthcare Research an...

Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight

DURATION-1 Data Presented at the 68th Annual Scientific Sessions of the American Diabetes Association SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ), and Alkermes, Inc. (Nasdaq: ALKS ) anno...

Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo

COLLEGEVILLE, Pa., March 30, 2007 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , Solvay Pharmaceuticals, Inc. and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week. Safety analyses suggest bifeprunox, an investigation...

New Data Confirm That Use of Levemir Can Limit Weight Gain

COPENHAGEN, April 3, 2007-Newly published results in the International Journal of Clinical Practice(1) from the large-scale, observational ‘PREDICTIVE™ study’*, confirm that Levemir® for the majority of people effectively treats diabetes without causing weight gain.(1) The ...

New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People

BUDAPEST, April 24 /CNW/ - The weight loss medication Xenical (orlistat 120mg) significantly reduces weight and improves cardiovascular risk factors such as blood pressure, glycaemic control and lipid profile in overweight and obese people with type 2 diabetes and hypertension, according to a study...

Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants

Study released at the Pediatric Academic Societies' Annual Meeting This Month in Toronto Shows That Switching to Masimo SET Pulse Oximetry Technology Can Reduce the Risk Associated with ROP by 40% IRVINE, Calif., May 30, 2007 /PRNewswire/ -- Masimo, the inventor of Pulse CO-Oximetry and Read-Throu...

Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 5, 2007 - Elixir Pharmaceuticals, Inc., announced today new preclinical data confirming ghrelin antagonism as a potential method for regulating metabolism, decreasing body weight and managing blood glucose. The data were presented in poster sessions during END...

Regular Yoga Practice Is Associated With Mindful Eating

...age spread in normal-weight people and may promote weight loss in those who are overweight. At the time, the...at middle-age people who practice yoga gained less weight over a 10-year period than those who did not. This... increases mindfulness in eating and leads to less weight gain over time, independent of the physical activi...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...se targets with antisense drugs can significantly lower blood glucose levels, increase the body's sensitivity to insulin, and reduce fat mass and body weight in animals. Isis partnered with non profit foundations to pursue new treatments for debilitating diseases, such as severe neurodege...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

...d points, with an improvement by the first week of therapy in "overall quality of sleep" and "awakening during the night". The incidence of agitation, weight gain and sexual dysfunction in patients administered Labopharm's trazodone was no different from placebo. The overall drop out rate in the study was 2...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

...he body's ineffective use of insulin. Type 2 diabetes comprises 90% of people with diabetes around the world, and is largely the result of excess body weight and physical inactivity. About Debiopharm Group Debiopharm Group is a Swiss-based global biopharmaceutical group of companies with a foc...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...lood sugar or diabetes, such as being thirsty all the time, having to urinate or "pass urine" more often than usual, or feeling weak or hungry. weight gain has been observed with INVEGA((R)) SUSTENNA(TM) and other atypical antipsychotic medications. If you notice that you are gaining weight, please n...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

...early three in four patients discontinue therapy within 18 months due to either poor tolerability or incomplete efficacy. Metabolic safety, including weight gain, elevation of lipid levels (dyslipidemia) and glucose dysregulation, is an important consideration with any antipsychotic treatment. Patients of...

Is Your Hair Taking a Break?

...ogic response to some form of stress, causing more hair to enter the rest phase than the normal 10 percent. For example, surgery, childbirth, dramatic weight loss (including gastric bypass surgery), the death of a loved one, starting or stopping oral contraceptives, iron deficiency, and chronic thyroid dise...

Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)

...failure. Talk to your doctor immediately if you experience unusually fast weight gain, fluid retention (swelling), shortness of breath, or unusual tiredness...flulike symptoms, mild-to-moderate swelling of legs and ankles, anemia, and weight gain. Patients with diabetes should have regular eye exams. If you experien...